PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16039276-0	2005	Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand White Rabbit.	Pioglitazone	0-12	apolipoprotein A-I	Oryctolagus cuniculus	98-104	
16039276-2	2005	Whether pioglitazone-mediated modifications in HDL-apolipoprotein AI (apo AI) turnover in vivo contribute to this effect has not been completely elucidated.	Pioglitazone	8-20	apolipoprotein A-I	Oryctolagus cuniculus	47-68	
16039276-2	2005	Whether pioglitazone-mediated modifications in HDL-apolipoprotein AI (apo AI) turnover in vivo contribute to this effect has not been completely elucidated.	Pioglitazone	8-20	apolipoprotein A-I	Oryctolagus cuniculus	70-76	
16039276-5	2005	Consequently, apo AI plasma levels in pioglitazone-treated animals were similar to those of controls.	Pioglitazone	38-50	apolipoprotein A-I	Oryctolagus cuniculus	14-20	
16039276-7	2005	Our data demonstrate that pioglitazone markedly modifies apo AI kinetics and enhances the proportion of small HDL3c particles, despite the unchanged apo AI concentration.	Pioglitazone	26-38	apolipoprotein A-I	Oryctolagus cuniculus	57-63